
Alarming rates of antibiotic resistance have led US state and local health departments to place increased pressure on healthcare providers to improve antibiotic prescription practices. A trend of intensified focus on antibiotic stewardship programs (ASP) is placing increasing demands on diagnostic laboratories to support the cause, particularly for those serving long-term care facilities (LTCFs), nursing homes, outpatient clinics, and skilled nursing facilities. For labs, this presents both a challenge and an opportunity.
This post presents the trends shaping ASP in these settings and explores innovative solutions that diagnostic labs can leverage to capitalize on this momentum.
The Centers for Medicare & Medicaid Services (CMS) and the Centers for Disease Control and Prevention (CDC) have escalated efforts to enforce antimicrobial stewardship practices. LTCFs, in particular, are under increased scrutiny, with CMS imposing penalties for non-compliance with ASP requirements.
The CDC highlights the critical role of ASP in combating the overuse of antibiotics, a problem that plagues 40–75% of prescriptions in nursing homes. By addressing these challenges, ASPs not only protect patients but also reduce the risk of antibiotic resistance, which experts predict will soon rival the impact of major public health crises like COVID-19.
Failure to implement effective ASP measures has wide-ranging implications:
For LTCFs, meeting ASP requirements isn’t just about compliance—it’s about securing their financial and operational stability.
The long-term care sector is increasingly embracing molecular diagnostics, such as PCR testing combined with traditional microbiology. This approach enables precise identification of pathogens, empowering facilities to make informed, evidence-based decisions about antimicrobial use.
Diagnostic labs have an opportunity to position themselves as essential partners by providing tools that align with these advancements.
Labs equipped with comprehensive ASP tools are invaluable to LTCFs. Arkstone’s advanced OneChoice® report is a prime example. It combines patient-specific data, such as organisms and resistance genes detected, patient allergies and diagnosis, and more, with treatment recommendations that provide pinpointed and targeted guidance based on the standard of care. This helps clinicians make informed decisions, ensuring compliance with ASP requirements while improving patient care. In addition, with Arkstone’s Fusion report, cultures and molecular data from a single sample or multiple samples are consolidated into one comprehensive recommendation, empowering healthcare providers to make accurate, well-informed decisions using different modalities of diagnostics simultaneously.
Additional capabilities, like monthly tracking and reporting tools for co-op meetings, give facilities a clear view of their antimicrobial usage and outcomes, aligning with CDC’s emphasis on tracking and reporting.
The CDC identifies seven core elements of effective ASPs: leadership, accountability, drug expertise, action, tracking, reporting, and education. Diagnostic labs that offer ASP programs incorporating these elements can serve as critical enablers for LTCFs striving to meet these standards.
“Antimicrobial stewardship often begins at the diagnostic level, where accurate and prompt detection of infections is critical for effective treatment. This underscores the growing importance of implementing stewardship practices seamlessly with the laboratory.”
Dr. Ari Frenkel, MD MPH. Chief Science Officer
Arkstone Medical Solutions
Effective antimicrobial stewardship programs (ASPs) bring substantial clinical and financial benefits to long-term care facilities.
Dendi’s laboratory information system (LIS) provides a modern, cloud-native platform designed to elevate laboratory operations. With advanced interoperability capabilities and rapid implementation, Dendi LIS’ advanced API ensures that labs can easily integrate with essential antimicrobial stewardship tools like Arkstone’s OneChoice® report.
Arkstone’s comprehensive ASP programs enable labs to provide LTCFs with:
Together, Dendi and Arkstone offer labs a turnkey solution to deliver actionable ASP insights, reduce operational friction, and ensure compliance with stringent healthcare regulations.
Chief Science Officer and infectious disease specialist, Dr. Frenkel notes that “antimicrobial stewardship often begins at the diagnostic level, where accurate and prompt detection of infections is critical for effective treatment. This underscores the growing importance of implementing stewardship practices as a collaboration with the laboratory, so that effective antimicrobial stewardship occurs the moment the infection is diagnosed, and the clinician receives their results.”

For labs, ASP isn’t just a compliance-driven necessity—it’s a competitive differentiator. Labs with integrated ASP capabilities can offer LTCFs a clear value proposition: compliance, cost savings, and better patient outcomes.
By aligning with ASP trends, labs can build stronger relationships with healthcare providers in skilled nursing facilities, opening doors to new business opportunities and long-term growth.
Antimicrobial stewardship is no longer optional for healthcare providers within the SNF setting, and diagnostic labs are uniquely positioned to support this mission. By integrating Dendi LIS with Arkstone’s OneChoice® report, labs can offer LTCFs the tools they need to succeed in a compliance-driven market.
Ready to transform your lab into a strategic partner for long-term care providers? Contact us today to learn more about how our integrated solutions can help your lab stay ahead in the evolving healthcare landscape.
Simplify. Integrate. Scale. Modernize your lab with Dendi today.